T90 Training the Global Ready Scholar (9 of 10)TL1

近年来，在许多情况下，癌症已经从死刑转变为一种导致许多人死亡的疾病 幸存者。积极的癌症治疗对患者的生活质量造成了重大影响。公认的 对于女性来说，化疗或放疗后的并发症是对卵巢的毒性，这会导致 卵母细胞受损或丢失，导致生育能力受损或丧失。肿瘤受精的目的 该联盟将通过培训全球准备好的劳动力来应对癌症治疗带来的生育威胁 拥有管理癌症女性生殖需求的专业知识。这样的影响 在妇女健康的一般领域的计划可以是巨大的产生一个多学科 医生应对生育问题的力量。肿瘤生育学科的长期成功 需要精心安排和重点发展的医生-科学家全球劳动力，这将 落实研究和临床议程，最终成为扩大和发展的原点 这一新的、跨学科的肿瘤生育领域。本T90/R90提案的目的是培训和教育 第一代肿瘤生育专家的研究直接关系到人类的生殖需求 癌症患者和幸存者。这样的教育和培训方案将为进一步的 这门处于肿瘤学、儿科学、生殖科学和 医学、生物力学、材料科学、数学、社会科学、生物伦理学、宗教、政策研究、 生殖健康法与认知科学和学习学。考虑到临床和研究培训研究员 接受，这个培训和教育计划的执行委员会认为，第一代 肿瘤生育专家应从生殖内分泌学和不孕不育的队伍中培养出来 (REI)，这是在完成驻院实习后为高级培训提供的四个子专业奖学金之一 妇产科。生殖医学高级培训的正式认证正在进行中 美国产科委员会生殖内分泌学和不孕不育部的支持 和妇科公司(ABOG)。研究是研究金方案的一个中心特征，因此， 建议的肿瘤生育培训计划与#年的临床和教育目标完全吻合 生殖内分泌学。拟议的肿瘤生育国家和国际培训方案将是 联邦政府支持的唯一机制是研究人员培训，这对进入 学术上的肿瘤生育专家。

In recent years, cancer has been converted, in many cases, from a death sentence to a disease of many survivors. Aggressive cancer treatments take a significant toll on patient's quality of life. A recognized complication for women after chemotherapy or radiation is the toxicity to the ovaries, which results in the damage or loss of oocytes leading to impairment or loss of fertility. The purpose of the Oncofertility Consortium is to attack the fertility threat posed by cancer treatment by training a globally ready workforce with the expertise to manage the reproductive needs of the woman with cancer. The impact of such a program in the general field of Women's Health canbe tremendous for generating a multidisciplinary force of doctors for coping with fertility concerns. The long-term success of the oncofertility discipline requires the well orchestrated and focused development of a physician-scientist global workforce, which will implement the research and clinical agenda and ultimately be the origin for the expansion and development of this new, interdisciplinary field of oncofertility. It is the intent of this T90/R90 proposal to train and educate the first generation of oncofertility specialists in research directly related to the reproductive needs of the cancer patient and survivor. Such education and training programs will provide the foundations for the further development of this discipline that is at the intersection of oncology, pediatrics, reproductive science and medicine, biomechanics, material science, mathematics, social science, bioethics, religion, policy research, reproductive health law and cognitive and learning science. Given the clinical and research training fellows receive, the executive committee of this training and educational program believes that the first generation of oncofertility specialists should be bred from within the ranks of Reproductive Endocrinology and Infertility (REI), which is one of four subspecialty fellowships for advanced training after completion of a residency in Obstetrics and Gynecology. Formal certification for this advanced training in Reproductive Medicine is under the aegis of the Division of Reproductive Endocrinology and Infertility of the American Board of Obstetrics and Gynecology, Inc. (ABOG). Research is a central feature of fellowship programs and, therefore, the proposed oncofertility training program dovetails perfectly with the clinical and educati9nal objectives in reproductive endocrinology. The proposed National and International Training Program in Oncofertility will be the ONLY federally supported mechanism for research training of fellows critical for entry into the pipeline of academic oncofertility specialists.